TCL Archive Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista March 12, 1999
TCL Archive NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan. March 11, 2005
TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006
TCL Archive In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval August 1, 1975
TCL Archive FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say January 26, 1996
